This article reviews the current literature related to the treatment of COPD exacerbations and examines whether these data support current treatment guidelines.

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

such as the NAEPP EPR-3 for asthma [101] and GOLD treatment guidelines for COPD, [102] both of which recognize the enduring risk of acute exacerbations. Knowledge of these treatment guidelines is ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

having a COPD treatment plan is key to breathing easier in the long term. What […] A COPD exacerbation doesn't just mean you're having a "bad day"-it's a sign that inflammation or infection in ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

So a COPD exacerbation is a period where people with COPD will notice an acute deterioration in their symptoms. And these will probably last a few days, and they may experience shortness of breath ...

And periodically they will have what we call an exacerbation ... function of patients with COPD so they can do the things that they want to do. That part of the treatment of the patient is ...

Recent medical research reveals promising developments in the treatment of patients suffering ... focused specifically on their effects on COPD exacerbations among diabetic patients.